Return to Previous Page
Details
The modified Aβ peptide is a prototype inhibitor of amyloid β-protein toxicity in vitro. It causes changes in aggregation kinetics of amyloid β-protein and higher structural characteristics of the aggregate. Residues 15 to 25 of the amyloid β-protein function as recognition element, and the lysines as disrupting element.
Links / Documents:
